GLP-1 Eligibility Checker
Use this GLP-1 eligibility checker for a preliminary adult starting-treatment screen. It cannot decide whether you should continue an existing prescription. Takes 30 seconds.
Do You Qualify for GLP-1 Weight-Loss Medication? (2026)
For adults starting weight-management treatment, the usual BMI screen is 30 or higher, or 27 or higher with a weight-related health condition. A clinician must confirm the diagnosis, safety and suitability; these measurements do not guarantee a prescription or insurance payment. This checker uses your current BMI. If you already take a GLP-1, a lower BMI after treatment does not by itself settle whether continued care is appropriate. Wegovy and Zepbound include long-term weight maintenance in their US indications. Review continuation with your treating clinician and ask your plan which renewal criteria apply. The continuation note below explains the distinction before you use the starting-treatment screen.
What BMI do you need to qualify for a GLP-1 like Wegovy or Zepbound?+
Which health conditions count toward qualifying at a BMI of 27 to 29.9?+
Who should NOT take GLP-1 weight-loss medication?+
Does meeting the BMI criteria guarantee I'll get a prescription?+
Is there a minimum age for GLP-1 weight-loss medication?+
Sources: Wegovy (semaglutide) FDA Prescribing Information, rev. 06/2026, Indications, Contraindications, Boxed Warning, Pancreatitis, Pregnancy · Zepbound (tirzepatide) FDA Prescribing Information, Indications, Contraindications, Acute Pancreatitis, Pregnancy · Zepbound (tirzepatide) Label on DailyMed (NIH/NLM) · FDA Press Announcement, FDA Approves New Medication for Chronic Weight Management (Zepbound)
Already taking a GLP-1: continuation needs a separate review
A lower current BMI alone does not tell you whether to stop or continue treatment. The US Wegovy prescribing information and Zepbound prescribing information include long-term weight maintenance. Ask your treating clinician to review your original diagnosis, treatment response and current health. Do not change treatment based on this calculator.
Insurance renewal is a separate check. For example, Cigna's September 2026 Wegovy injection policy considers BMI before treatment in its adult continuation criteria. Other requirements apply, and your benefit document controls coverage. This is not a promise that your plan or a new provider will approve continued care.
Use our insurance lookup to prepare plan questions. If you are changing services, read the provider-switching guide and confirm how the receiving clinician assesses existing patients before paying.